Subcutaneous Panniculitis-Like T-Cell Lymphoma: A Case Report

Main Article Content

David Dayi Xiong
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University

Brandon Tyler Beal
Department of Dermatology, Cleveland Clinic, OH

Manisha Manmohan
Department of Dermatology, Cleveland Clinic, OH

Maria Georgina Uberti
Departments of Anatomic Pathology and Dermatology, Cleveland Clinic, OH

Kathryn Riley
Department of Dermatology, Cleveland Clinic

Anthony Fernandez
Department of Dermatology, Cleveland Clinic

Keywords

cutaneous T-cell lymphoma, T-cell lymphoma, chemotherapy, cutaneous lymphoma

Abstract

We present a case of a woman diagnosed with subcutaneous panniculitis-like T-cell lymphoma treated with prednisone and methotrexate with sustained symptom remission, suggesting that uncomplicated subcutaneous panniculitis-like T-cell lymphoma can be managed effectively without multiagent chemotherapy or radiation.

References

1. Willemze R, Jansen PM, Cerroni L, et al. Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group Study of 83 cases. Blood. 2008;111(2):838-845. doi:10.1182/blood-2007-04-087288

2. Parveen Z, Thompson K. Subcutaneous Panniculitis-like T-Cell Lymphoma: Redefinition of Diagnostic Criteria in the Recent World Health Organization–European Organization for Research and Treatment of Cancer Classification for Cutaneous Lymphomas. Arch Pathol Lab Med. 2009;133(2):303-308. doi:10.1043/1543-2165-133.2.303

3. Swerdlow S, Campo E, Harris N, Jaffe E, Pileri S, Stein H. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, Fourth Edition. Lyon, France: IARC; 2008.

4. Go RS, Wester SM. Immunophenotypic and molecular features, clinical outcomes, treatments, and prognostic factors associated with subcutaneous panniculitis-like T-cell lymphoma. Cancer. 2004;101(6):1404-1413. doi:10.1002/cncr.20502

5. Guenova E, Schanz S, Hoetzenecker W, et al. Systemic corticosteroids for subcutaneous panniculitis-like T-cell lymphoma. Br J Dermatol. 2014;171(4):891-894. doi:10.1111/bjd.13053

Article Sidebar

PDF
Published
Jan 28, 2020
DOI https://doi.org/10.25251/skin.4.1.13

Article Details

How to Cite
Xiong, D. D., Beal, B. T., Manmohan, M., Uberti, M. G., Riley, K., & Fernandez, A. (2020). Subcutaneous Panniculitis-Like T-Cell Lymphoma: A Case Report. SKIN The Journal of Cutaneous Medicine, 4(1), 79–81. https://doi.org/10.25251/skin.4.1.13
Issue
Vol. 4 No. 1 (2020): January Issue & Poster Presentations (2020 Winter Clinical Dermatology Conference®)
Section
Brief Articles
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All authors retain copyright in their articles. All articles published open access allowing for immediate free access to the work and permitting any user to read, download, copy, distribute, print, search, or link to the full texts of articles, crawl them for indexing, pass them as data to software or use them for any other lawful purpose. Permitted reuse is defined by  the following user license:
 

Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation. 

Authors retain copyright in their work and license the publisher to publish the content. The publisher is the National Society for Cutaneous Medicine, with production and publishing support provided by OJS, Open Journal Systems,see https://pkp.sfu.ca/ojs/.

Prior to January 2022, authors transferred copyright to the National Society for Cutaneous Medicine. However, all articles are freely available to anyone in the world. There are no subscription fees, page charges, or article processing charges.